As the COVID-19 pandemic continues, the development of antiviral drug treatments has become a critical weapon in our arsenal against the virus. Harnessing the research and scientific brainpower needed to treat and prevent the next pandemic is the University of California - National Labs Antiviral Treatments Targeting All Coronaviruses and…
UC Davis Medical Center is reporting its highest-ever number of COVID-19 patients. As of Jan. 18, there were 126 patients with active COVID-19 – a 300% increase since Jan. 1. Admissions of both pediatric and adult patients have spiked in recent days.
For years, physicians have been taught to prescribe different drugs to Black people with high blood pressure. A recent UCSF study calls that into question.
Many patients with COVID-19 develop brain fog and other cognitive symptoms months later. Their cerebrospinal fluid may hold clues to why this is happening.
Sergio Aguilar-Gaxiola of UC Davis is one of seven national leaders who wrote an article in the New England Journal of Medicine urging the clinical and translational research community to advance diversity, equity and inclusion in their work as a way to address structural health inequities.
